7 results match your criteria: "General Hospital of Athens 'Gennimatas'[Affiliation]"

Article Synopsis
  • The pathophysiology of pediatric hydrocephalus remains unclear, and valve-based shunt systems have been the primary treatment option since the 1950s, transitioning from ventricular-atrial systems to peritoneal systems in the 1970s.
  • The review highlights the comparison of valve types and emphasizes endoscopic third ventriculostomy (ETV) as the only surgical alternative today, which offers lower infection and re-operation rates, especially for children with previous shunt failures.
  • It also identifies key predictive factors for ETV success and attempts to determine optimal treatment strategies for different patient subgroups, aiming to improve long-term outcomes for pediatric hydrocephalus patients.
View Article and Find Full Text PDF

Advanced Therapy Medicinal Products as Potential Therapeutic Strategy against COVID-19 and Immune-Related Disorders.

Int J Mol Sci

March 2024

Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens (BRFAA), 115 27 Athens, Greece.

Advanced Therapy Medicinal Products (ATMPs) comprise a heterogenous class of innovative medicinal products, which further require extensive preclinical and clinical assessments before their broader use in the general population [...

View Article and Find Full Text PDF

Introduction: Transperineal laser ablation (TPLA) of the prostate is a new, minimally invasive technique for benign prostatic hyperplasia (BPH) with promising effectiveness and safety outcomes. This systematic review aims to provide an update of existing literature.

Methods: A literature review was performed in Pubmed/MEDLINE, Embase, Cochrane Library, and clinicaltrials.

View Article and Find Full Text PDF

Exploring the Immunomodulatory Properties of Stem Cells in Combating COVID-19: Can We Expect More?

Bioengineering (Basel)

July 2023

Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 115 27 Athens, Greece.

Since the first appearance of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in December 2019, the disease has displayed a remarkable interindividual variability in the global population, resulting in different mortality and morbidity rates. Still, an effective cure against SARS-CoV-2 has not been developed, and therefore, alternative therapeutic protocols must also be evaluated. Considering that stem cells, especially Mesenchymal Stromal Cells (MSCs), are characterized by both regenerative and immunomodulatory properties and that their safety and tolerability have been investigated previously, these cells could potentially be applied against coronavirus disease 19 (COVID-19).

View Article and Find Full Text PDF

Cerebellar mutism syndrome (CMS), also known as posterior fossa syndrome, is an entity that entails a constellation of signs and symptoms which are recorded in a limited number of pediatric patients who have been operated on mainly for tumors involving the posterior cranial fossa, and more precisely, the region of the vermis. Medulloblastoma seems to constitute the most commonly recognized pathological substrate, associated with this entity. The most prevalent constituents of this syndrome are noted to be a, often transient, although protracted, language impairment, emotional lability, along with cerebellar and brainstem dysfunction.

View Article and Find Full Text PDF

Design and Fabrication of Artificial Stem Cell Microenvironments.

Bioengineering (Basel)

December 2022

Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 115 27 Athens, Greece.

Major key features of stem cells' functions are self-renewal and their capacity for differentiation, allowing for maintain a proper stem cell reservoir as well as producing lineage-committed cells [...

View Article and Find Full Text PDF